Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-09

Clinical Trial Update: Effects of Personalized Digital Reminiscence Therapy on Patients With Neurocognitive Disorders

View source ↗

Summary

A clinical trial is evaluating the effects of personalized digital reminiscence therapy in patients with mild neurocognitive disorders and related mood/symptom …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: KompanionCare SAS | Conditions: Neurocognitive Disorders, Mild, Cognitive Impairment, Mild | Status: RECRUITING